Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Clinuvel Pharmaceuticals Limited (AU:CUV)
ASX:CUV
RESEARCH TOOLSreports
Holding AU:CUV?
Track your performance easily
Clinuvel Pharmaceuticals Limited (CUV) Ownership Overview
22.44% Insiders
2.80% Mutual Funds
2.58% Other Institutional Investors
72.18% Public Companies and
Individual Investors
The ownership structure of Clinuvel Pharmaceuticals Limited (AU:CUV) stock is a mix of institutional, retail and individual investors. Approximately 5.37% of the company’s stock is owned by Institutional Investors, 22.44% is owned by Insiders and 72.18% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 20, 2023 | Philippe Jacques Wolgen Chief Executive Officer & Managing Director | xxxxxxxxxxxxx | AU$29814 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,406,679 | Insider | 10.80% | 80,992,051 | |
| 3,425,222 | Insider | 6.84% | 51,309,826 | |
| 1,743,118 | Insider | 3.48% | 26,111,908 | |
| 605,285 | Institution | 1.21% | 6,130,932 | |
| 603,669 | Institution | 1.21% | 6,114,563 | |
| 506,117 | Institution | 1.01% | 5,126,459 | |
| 385,745 | Institution | 0.77% | 3,907,211 | |
| 233,006 | Institution | 0.47% | 2,360,118 | |
| 196,577 | Insider | 0.39% | 2,944,723 | |
| 187,774 | Insider | 0.37% | 2,812,855 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 603,669 | Institution | 1.21% | 6,114,563 | |
| 385,745 | Institution | 0.77% | 3,907,211 | |
| 233,006 | Institution | 0.47% | 2,360,118 | |
| 83,814 | Institution | 0.17% | 848,952 | |
| 35,496 | Institution | 0.07% | 359,539 | |
| 18,967 | Institution | 0.04% | 192,117 | |
| 11,610 | Institution | 0.02% | 117,598 | |
| 11,263 | Institution | 0.02% | 114,083 | |
| 6,455 | Institution | 0.01% | 65,383 | |
| 5,000 | Institution | <0.01% | 50,645 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 385,745 | Institution | 0.77% | 3,776,954 | |
| 226,850 | Institution | 0.45% | 2,314,712 | |
| 154,229 | Institution | 0.31% | 1,510,106 | |
| 128,729 | Institution | 0.26% | 1,313,514 | |
| 83,073 | Institution | 0.17% | 851,786 | |
| 65,960 | Institution | 0.13% | 673,037 | |
| 57,303 | Institution | 0.11% | 561,072 | |
| 39,728 | Institution | 0.08% | 407,351 | |
| 17,329 | Institution | 0.03% | 241,461 | |
| 17,329 | Institution | 0.03% | 241,461 |
FAQ
Who Owns Clinuvel Pharmaceuticals Limited (AU:CUV)?
According to the latest TipRanks data, approximately 2.58% of the company's stock is held by institutional investors, 22.44% is held by insiders, and 72.18% is held by retail investors.
What percentage of Clinuvel Pharmaceuticals Limited (AU:CUV) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.58% of Clinuvel Pharmaceuticals Limited (AU:CUV) stock is held by institutional investors.
What percentage of Clinuvel Pharmaceuticals Limited (AU:CUV) stock is held by retail investors?
According to the latest TipRanks data, approximately 72.18% of Clinuvel Pharmaceuticals Limited (AU:CUV) stock is held by retail investors.
Who owns the most shares of Clinuvel Pharmaceuticals Limited (AU:CUV)?
Wayne Andrew Millen owns the most shares of Clinuvel Pharmaceuticals Limited (AU:CUV).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.